Results 281 to 290 of about 240,251 (364)

Trans-synaptic molecular context of NMDA receptor nanodomains. [PDF]

open access: yesNat Commun
Anderson MC   +6 more
europepmc   +1 more source

Cyanide Beyond Toxicity: A Systematic Review of Its Effects on Vascular Function

open access: yesBasic &Clinical Pharmacology &Toxicology, Volume 137, Issue 5, November 2025.
ABSTRACT Cyanide is widely recognized for its potent toxicity, yet evidence shows that concentrations below 1 μM may enhance cytochrome c oxidase activity and have a regulatory function. Recent findings also demonstrate that mammalian cells, including endothelial cells, produce cyanide endogenously, where it can modulate mitochondrial bioenergetics ...
Elif Alan‐Albayrak, Ulf Simonsen
wiley   +1 more source

Nitrergic Signaling Mediation of Neurobehavioral Responses to Stress in Zebrafish. [PDF]

open access: yesJ Neurochem
Heymbeeck JAA   +4 more
europepmc   +1 more source

Cannabinoid CB2 receptor‐mediated analgesia: mechanism‐based insights and therapeutic potential

open access: yesBritish Journal of Pharmacology, Volume 182, Issue 21, Page 5090-5118, November 2025.
Agonists of the cannabinoid 2 (CB2) receptor have shown promise for the treatment of pain in a variety of animal models. However, despite current preclinical evidence supporting the use of CB2 agonists for pain, successful translation of findings from preclinical models to human patients is lacking.
Kelsey G. Guenther, Andrea G. Hohmann
wiley   +1 more source

Genetic testing in cerebral palsy with clinical and neuroimaging variables

open access: yesDevelopmental Medicine &Child Neurology, Volume 67, Issue 11, Page 1443-1452, November 2025.
This original article is commented by Krägeloh‐Mann on pages 1376–1377 of this issue. Plain language summary: https://onlinelibrary.wiley.com/doi/10.1111/dmcn.16334 Abstract Aim To optimize genetic testing in children with cerebral palsy (CP) by using clinical and magnetic resonance imaging (MRI) variables.
Esther M. Tantsis   +46 more
wiley   +1 more source

Targeting metabotropic glutamate receptors for symptomatic and disease-modifying treatment in Parkinson's disease. [PDF]

open access: yesNPJ Parkinsons Dis
Alborghetti M   +5 more
europepmc   +1 more source

Neuroendocrinology meets addiction: Emerging pharmacotherapies on the horizon

open access: yesJournal of Internal Medicine, Volume 298, Issue 5, Page 392-423, November 2025.
Abstract Alcohol and other substance use disorders (ASUDs) are prevalent and major contributors to global morbidity and mortality. Their impact extends beyond the individual, imposing significant burdens on families, communities, healthcare systems, and society at large.
Anna Loften   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy